Citation Formats
Canakinumab in patients with FMF
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. Hacıoğlu Et Al. , "Canakinumab in patients with FMF," International Society of Systemic Auto-Inflammatory Diseases (ISSAID) , Lausanne, Switzerland, pp.65, 2013

Hacıoğlu, A. Et Al. 2013. Canakinumab in patients with FMF. International Society of Systemic Auto-Inflammatory Diseases (ISSAID) , (Lausanne, Switzerland), 65.

Hacıoğlu, A., Uğurlu, S., Seyahi, E., Hatemi, G., & Özdoğan, A. H., (2013). Canakinumab in patients with FMF . International Society of Systemic Auto-Inflammatory Diseases (ISSAID) (pp.65). Lausanne, Switzerland

Hacıoğlu, AYŞA Et Al. "Canakinumab in patients with FMF," International Society of Systemic Auto-Inflammatory Diseases (ISSAID), Lausanne, Switzerland, 2013

Hacıoğlu, AYŞA Et Al. "Canakinumab in patients with FMF." International Society of Systemic Auto-Inflammatory Diseases (ISSAID) , Lausanne, Switzerland, pp.65, 2013

Hacıoğlu, A. Et Al. (2013) . "Canakinumab in patients with FMF." International Society of Systemic Auto-Inflammatory Diseases (ISSAID) , Lausanne, Switzerland, p.65.

@conferencepaper{conferencepaper, author={AYŞA HACIOĞLU Et Al. }, title={Canakinumab in patients with FMF}, congress name={International Society of Systemic Auto-Inflammatory Diseases (ISSAID)}, city={Lausanne}, country={Switzerland}, year={2013}, pages={65} }